Stories
Healthcare Pricing Needs Regulatory Certainty Along With Price Controls
C
CNBC TV18•19-10-2026, 14:17
Healthcare Pricing Needs Regulatory Certainty Along With Price Controls
- •Patients must be protected from predatory pricing, but regulation must also avoid weakening the healthcare system and long-term sustainability.
- •Regulatory predictability and ease of doing business are critical to attracting necessary capital and private investment into India healthcare infrastructure.
- •A uniform pricing approach fails to account for the diverse economics of routine consumables, advanced medical devices, and hospital services.
- •Policymakers should rely on evidence-based data and structured consultations to target unjustified margins without stifling innovation and R and D.
- •India can successfully balance patient protection and investment by building a transparent, accountable, and proportionate regulatory framework.
Key Questions Answered
While protecting patients from predatory pricing is essential, regulation must be intelligently designed and enforced to avoid harming healthcare access, quality, innovation, and long-term investment sustainability.
Investors commit significant capital for long horizons into hospitals and pharmaceuticals. A stable regulatory environment gives businesses clear visibility and builds the necessary investor sentiment to expand India's healthcare capacity.
Different categories like medical consumables, advanced therapies, and hospital services have distinct supply chains and economics. A uniform pricing approach can cause cascading effects that stifle indigenous R&D and innovation.
